Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound

Sponsor
Connecticut Children's Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05971745
Collaborator
Columbia University (Other), Newark Beth Israel Medical Center (Other), Cohen Children's Medical Center (Other), Gold Coast Hospital and Health Service (Other), Yale University (Other)
160
6
54.3
26.7
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if pediatric emergency medicine providers can accurately diagnose a hip effusion using point-of-care ultrasound (POCUS) compared to radiology ultrasound (RADUS).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The purpose of this study is to determine that the accuracy of trained pediatric emergency medicine providers to diagnose hip effusion using point-of-care ultrasound (POCUS) is non-inferior to the reference standard of radiology ultrasound (RADUS). Additionally, the investigators seek to compare how POCUS performs against other clinical tests or investigations for the diagnosis of septic arthritis. The investigators hypothesize that trained EM providers will be able to diagnose hip effusions with high (>90%) accuracy compared to studies conducted by the Department of Radiology.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    160 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound
    Actual Study Start Date :
    Oct 15, 2019
    Anticipated Primary Completion Date :
    Apr 25, 2024
    Anticipated Study Completion Date :
    Apr 25, 2024

    Outcome Measures

    Primary Outcome Measures

    1. The presence or absence of a hip effusion. [From the time the point-of-care ultrasound is performed by the physician during the emergency department visit through study completion, average of 2 years.]

      The presence or absence of an effusion as determined by the pediatric emergency medicine physician performing the point-of-care-ultrasound study on both the affected and unaffected sides (i.e. right hip and left hip).

    2. The presence of absence of a hip effusion. [From the time the radiologist reviews the ultrasound as performed by the radiology technician during the emergency department visit, through study completion, average of 2 years.]

      The presence or absence of an effusion as determined by the Radiologist on both the affected and unaffected sides.

    Secondary Outcome Measures

    1. The size of the effusion. [From the time the point-of-care ultrasound is performed by the physician during the emergency department visit to study completion, average of 2 years]

      As measured by the pediatric emergency medicine provider in millimeters.

    2. The location of the measurement of the effusion. [Upon chart review: between the time the measurement was obtained in the emergency department up to six weeks later when the chart is reviewed by primary investigator.]

      Pediatric emergency medicine physicians will measure an effusion at two designated locations. One location is based off of current published literature whereas the second is to provide a comparison to determine if the exact location alters the final diagnosis (effusion or no effusion). Investigators will determine whether the location along the angle of the neck affects the measurement obtained when compared with the current standard practice of measuring fluid along the widest part of the femoral neck.

    Other Outcome Measures

    1. Number of point-of-care ultrasound studies performed by PEM providers that have a different final diagnosis when compared to radiology ultrasound. [Upon chart review: between the time the measurement was obtained in the emergency department up to six weeks later when the chart is reviewed by primary investigator.]

      Investigators will compare the final diagnosis (hip effusion or no hip effusion) between point-of-care-ultrasound and radiology ultrasound to determine the number of discrepancies between the groups.

    2. Association between negative point-of-care ultrasound and low to moderate Kocher score. [Upon chart review: between the time the measurement was obtained in the emergency department up to six weeks later when the chart is reviewed by primary investigator.]

      Investigators will determine whether the use of ultrasonography in patients with low or moderate Kocher score improves the ability to rule out septic arthritis.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age 18 years or younger

    • Clinical presentation necessitating hip ultrasonography as determined by the evaluating clinician

    • Study physician available at the time of presentation to ED

    • Patient or legal guardian provides consent

    Exclusion Criteria:
    • Children who present when a study physician is not available or those for whom consent is not given.

    • Children who have had hip ultrasound imaging prior to their ED visit. Children with prior hip/pelvis x-rays will not be excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ruchika M Jones Hartford Connecticut United States 06106
    2 Yale University New Haven Connecticut United States 06550
    3 Newark Beth Israel Medical Center Newark New Jersey United States 07112
    4 Cohen Children's Medical Center New Hyde Park New York United States 11042
    5 Columbia University Medical Center New York New York United States 10032
    6 Gold Coast Hospital and Health Service Southport Queensland Australia 4211

    Sponsors and Collaborators

    • Connecticut Children's Medical Center
    • Columbia University
    • Newark Beth Israel Medical Center
    • Cohen Children's Medical Center
    • Gold Coast Hospital and Health Service
    • Yale University

    Investigators

    • Principal Investigator: Ruchika M Jones, MD, MS, Connecticut Children's

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ruchika Jones, Principal Investigator, Connecticut Children's Medical Center
    ClinicalTrials.gov Identifier:
    NCT05971745
    Other Study ID Numbers:
    • 19-117
    First Posted:
    Aug 2, 2023
    Last Update Posted:
    Aug 2, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ruchika Jones, Principal Investigator, Connecticut Children's Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 2, 2023